ALFA FinderBSE filing, NSE: LICI. Summary written from the filing by ALFA Finder's alert engine.
Life Insurance Corporation of India: key numbers
- Share price
- ₹394.00
- Market cap
- ₹4,98,410 Cr
- Revenue (annual)
- ₹9,77,772 Cr
- Net profit (annual)
- ₹57,453 Cr
- P/E (TTM)
- 8.0×Sector 20.6×
- Promoter holding
- 90.00%-6.50% QoQ
- FII holding
- 1.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Life Insurance Corporation of India
All →Life Insurance Corporation of India Results Correction
LIC corrected a unit error in its November 5, 2026 results press release, changing AUM from Rs 59,60,941 lakh crore to crore. The results themselves are unchanged.
Life Insurance Corporation of India Investor Presentation: Key Takeaways
H1 FY27: PAT INR 25,568 Cr (+21.5%), Net VNB INR 6,846 Cr (+34%), VNB margin 22.3% (+4.7ppt). IEV INR 7,97,378 Cr, down YoY from 8,13,230 Cr.
Life Insurance Corporation of India Q2 FY27 Results: Net Profit ₹12,115 Cr, Up 20.0% YoY
Life Insurance Corporation of India reported revenue from operations of ₹263,073 Cr (+9.5% YoY) and net profit of ₹12,115 Cr (+20.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12,115 Cr · +20.0% YoY
Life Insurance Corporation of India Management Change
LIC announced superannuation of four Senior Management Personnel w.e.f. October 31, 2026. All four Executive Directors and one Zonal Manager will be relieved by close of office on October 30, 2026.
Life Insurance Corporation of India Other Announcement
This is a quarterly shareholding pattern filing for Life Insurance Corporation of India for the period ended September 30, 2026.
Life Insurance Corporation of India Board Meeting Date
LIC intimated that its Board is scheduled for 05 Nov 2026 to approve Q2 and half-year financial results. Trading window for insiders is closed from 01 Oct 2026 until 48 hours post-meeting.
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.